Global Natural Killer (NK) Cell Therapeutics Market Insights and Forecast to 2028

Q: How big is the natural killer nk cell therapeutics market?

Natural killer cells are a type of cytotoxic lymphocyte which is a component of the innate immune system.Market Analysis and Insights Global Natural Killer NK Cell Therapeutics MarketThe global Natural Killer NK Cell Therapeutics market size is projected to reach US 1158.2 million by 2028 from US 255.8 million in 2021 at a CAGR of 23.7 during 20222028.Fully considering the economic change by this health crisis Mogamulizumab accounting for of the Natural Killer NK Cell Therapeutics global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

Q: Who are the key players in the natural killer nk cell therapeutics market?

Some of the key players are NKT Therapeutics USA, BristolMyers Squibb, NantKwest Inc USA, Sorrento Therapeutics Inc USA, Takeda Pharmaceutical Company Limited, Altor BioScience Corporation, Chipscreen Biosciences Ltd, 100 Basket, Affimed NV, Innate Pharma SA, Chipscreen Biosciences, Altor Bioscience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest Inc, Bristol–Myers Squibb, NKT, Henry Ford Health Services, Others.

Code: QYRE-Othe-183

Report

January 2022

Pages:110

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

NKT Therapeutics USA

BristolMyers Squibb

NantKwest Inc USA

Sorrento Therapeutics Inc USA

Takeda Pharmaceutical Company Limited

Altor BioScience Corporation

Chipscreen Biosciences Ltd

100 Basket

Affimed NV

Innate Pharma SA

Chipscreen Biosciences

Altor Bioscience

Innate Pharma

Takeda

Sorrento Therapeutics

NantKwest Inc

Bristol–Myers Squibb

NKT

Henry Ford Health Services

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.

Market Analysis and Insights: Global Natural Killer (NK) Cell Therapeutics Market

The global Natural Killer (NK) Cell Therapeutics market size is projected to reach US$ 1158.2 million by 2028, from US$ 255.8 million in 2021, at a CAGR of 23.7% during 2022-2028.

Fully considering the economic change by this health crisis, Mogamulizumab accounting for % of the Natural Killer (NK) Cell Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Cancer segment is altered to an % CAGR throughout this forecast period.

China Natural Killer (NK) Cell Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Natural Killer (NK) Cell Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Natural Killer (NK) Cell Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Natural Killer (NK) Cell Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Natural Killer (NK) Cell Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Natural Killer (NK) Cell Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Natural Killer (NK) Cell Therapeutics market.

Global Natural Killer (NK) Cell Therapeutics Scope and Market Size

Natural Killer (NK) Cell Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Natural Killer (NK) Cell Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Mogamulizumab

Lorvotuzumab Mertansine

Others

Segment by Application

Cancer

Cardiovascular Diseases

Others

BY COMPANY

Chipscreen Biosciences

Affimed NV

Altor BioScience

Innate Pharma

Takeda

Sorrento Therapeutics

NantKwest

Bristol-Myers Squibb

NKT

Henry Ford Health Services

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

NKT Therapeutics USA

BristolMyers Squibb

NantKwest Inc USA

Sorrento Therapeutics Inc USA

Takeda Pharmaceutical Company Limited

Altor BioScience Corporation

Chipscreen Biosciences Ltd

100 Basket

Affimed NV

Innate Pharma SA

Chipscreen Biosciences

Altor Bioscience

Innate Pharma

Takeda

Sorrento Therapeutics

NantKwest Inc

Bristol–Myers Squibb

NKT

Henry Ford Health Services

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Mogamulizumab

1.2.3 Lorvotuzumab Mertansine

1.2.4 Others

1.3 Market by Application

1.3.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Cancer

1.3.3 Cardiovascular Diseases

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Natural Killer (NK) Cell Therapeutics Market Perspective (2017-2028)

2.2 Natural Killer (NK) Cell Therapeutics Growth Trends by Region

2.2.1 Natural Killer (NK) Cell Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Natural Killer (NK) Cell Therapeutics Historic Market Size by Region (2017-2022)

2.2.3 Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2023-2028)

2.3 Natural Killer (NK) Cell Therapeutics Market Dynamics

2.3.1 Natural Killer (NK) Cell Therapeutics Industry Trends

2.3.2 Natural Killer (NK) Cell Therapeutics Market Drivers

2.3.3 Natural Killer (NK) Cell Therapeutics Market Challenges

2.3.4 Natural Killer (NK) Cell Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue

3.1.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue (2017-2022)

3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2017-2022)

3.2 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Natural Killer (NK) Cell Therapeutics Revenue

3.4 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio

3.4.1 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2021

3.5 Natural Killer (NK) Cell Therapeutics Key Players Head office and Area Served

3.6 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service

3.7 Date of Enter into Natural Killer (NK) Cell Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer (NK) Cell Therapeutics Breakdown Data by Type

4.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2017-2022)

4.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2023-2028)

5 Natural Killer (NK) Cell Therapeutics Breakdown Data by Application

5.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)

6.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type

6.2.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)

6.2.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)

6.2.3 North America Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)

6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Application

6.3.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)

6.3.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)

6.3.3 North America Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)

6.4 North America Natural Killer (NK) Cell Therapeutics Market Size by Country

6.4.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022)

6.4.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)

7.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type

7.2.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)

7.2.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)

7.2.3 Europe Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)

7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application

7.3.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)

7.3.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)

7.3.3 Europe Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)

7.4 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country

7.4.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022)

7.4.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)

8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type

8.2.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)

8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application

8.3.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)

8.4 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region

8.4.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)

9.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type

9.2.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)

9.2.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)

9.2.3 Latin America Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)

9.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application

9.3.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)

9.3.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)

9.3.3 Latin America Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)

9.4 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country

9.4.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022)

9.4.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)

10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type

10.2.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)

10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application

10.3.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)

10.4 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country

10.4.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Chipscreen Biosciences

11.1.1 Chipscreen Biosciences Company Details

11.1.2 Chipscreen Biosciences Business Overview

11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Introduction

11.1.4 Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.1.5 Chipscreen Biosciences Recent Developments

11.2 Affimed NV

11.2.1 Affimed NV Company Details

11.2.2 Affimed NV Business Overview

11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Introduction

11.2.4 Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.2.5 Affimed NV Recent Developments

11.3 Altor BioScience

11.3.1 Altor BioScience Company Details

11.3.2 Altor BioScience Business Overview

11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Introduction

11.3.4 Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.3.5 Altor BioScience Recent Developments

11.4 Innate Pharma

11.4.1 Innate Pharma Company Details

11.4.2 Innate Pharma Business Overview

11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Introduction

11.4.4 Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.4.5 Innate Pharma Recent Developments

11.5 Takeda

11.5.1 Takeda Company Details

11.5.2 Takeda Business Overview

11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Introduction

11.5.4 Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.5.5 Takeda Recent Developments

11.6 Sorrento Therapeutics

11.6.1 Sorrento Therapeutics Company Details

11.6.2 Sorrento Therapeutics Business Overview

11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Introduction

11.6.4 Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.6.5 Sorrento Therapeutics Recent Developments

11.7 NantKwest

11.7.1 NantKwest Company Details

11.7.2 NantKwest Business Overview

11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Introduction

11.7.4 NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.7.5 NantKwest Recent Developments

11.8 Bristol-Myers Squibb

11.8.1 Bristol-Myers Squibb Company Details

11.8.2 Bristol-Myers Squibb Business Overview

11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Introduction

11.8.4 Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.8.5 Bristol-Myers Squibb Recent Developments

11.9 NKT

11.9.1 NKT Company Details

11.9.2 NKT Business Overview

11.9.3 NKT Natural Killer (NK) Cell Therapeutics Introduction

11.9.4 NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.9.5 NKT Recent Developments

11.10 Henry Ford Health Services

11.10.1 Henry Ford Health Services Company Details

11.10.2 Henry Ford Health Services Business Overview

11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Introduction

11.10.4 Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

11.10.5 Henry Ford Health Services Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

NKT Therapeutics USA

BristolMyers Squibb

NantKwest Inc USA

Sorrento Therapeutics Inc USA

Takeda Pharmaceutical Company Limited

Altor BioScience Corporation

Chipscreen Biosciences Ltd

100 Basket

Affimed NV

Innate Pharma SA

Chipscreen Biosciences

Altor Bioscience

Innate Pharma

Takeda

Sorrento Therapeutics

NantKwest Inc

Bristol–Myers Squibb

NKT

Henry Ford Health Services

List of Tables

Table 1. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Mogamulizumab

Table 3. Key Players of Lorvotuzumab Mertansine

Table 4. Key Players of Others

Table 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 8. Global Natural Killer (NK) Cell Therapeutics Market Share by Region (2017-2022)

Table 9. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 10. Global Natural Killer (NK) Cell Therapeutics Market Share by Region (2023-2028)

Table 11. Natural Killer (NK) Cell Therapeutics Market Trends

Table 12. Natural Killer (NK) Cell Therapeutics Market Drivers

Table 13. Natural Killer (NK) Cell Therapeutics Market Challenges

Table 14. Natural Killer (NK) Cell Therapeutics Market Restraints

Table 15. Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2017-2022) & (US$ Million)

Table 16. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players (2017-2022)

Table 17. Global Top Natural Killer (NK) Cell Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2021)

Table 18. Ranking of Global Top Natural Killer (NK) Cell Therapeutics Companies by Revenue (US$ Million) in 2021

Table 19. Global 5 Largest Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue (CR5 and HHI) & (2017-2022)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service

Table 22. Date of Enter into Natural Killer (NK) Cell Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 25. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2017-2022)

Table 26. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 27. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2023-2028)

Table 28. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 29. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application (2017-2022)

Table 30. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 31. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application (2023-2028)

Table 32. North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 33. North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 34. North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 35. North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 36. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 37. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 38. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 39. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 40. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 41. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 42. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 43. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 44. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 45. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 46. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 47. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 48. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 49. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2023-2028) & (US$ Million)

Table 50. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 51. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 52. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 53. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 54. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 55. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 56. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 57. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 58. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 59. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 60. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 61. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 62. Chipscreen Biosciences Company Details

Table 63. Chipscreen Biosciences Business Overview

Table 64. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product

Table 65. Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 66. Chipscreen Biosciences Recent Developments

Table 67. Affimed NV Company Details

Table 68. Affimed NV Business Overview

Table 69. Affimed NV Natural Killer (NK) Cell Therapeutics Product

Table 70. Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 71. Affimed NV Recent Developments

Table 72. Altor BioScience Company Details

Table 73. Altor BioScience Business Overview

Table 74. Altor BioScience Natural Killer (NK) Cell Therapeutics Product

Table 75. Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 76. Altor BioScience Recent Developments

Table 77. Innate Pharma Company Details

Table 78. Innate Pharma Business Overview

Table 79. Innate Pharma Natural Killer (NK) Cell Therapeutics Product

Table 80. Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 81. Innate Pharma Recent Developments

Table 82. Takeda Company Details

Table 83. Takeda Business Overview

Table 84. Takeda Natural Killer (NK) Cell Therapeutics Product

Table 85. Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 86. Takeda Recent Developments

Table 87. Sorrento Therapeutics Company Details

Table 88. Sorrento Therapeutics Business Overview

Table 89. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product

Table 90. Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 91. Sorrento Therapeutics Recent Developments

Table 92. NantKwest Company Details

Table 93. NantKwest Business Overview

Table 94. NantKwest Natural Killer (NK) Cell Therapeutics Product

Table 95. NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 96. NantKwest Recent Developments

Table 97. Bristol-Myers Squibb Company Details

Table 98. Bristol-Myers Squibb Business Overview

Table 99. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product

Table 100. Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 101. Bristol-Myers Squibb Recent Developments

Table 102. NKT Company Details

Table 103. NKT Business Overview

Table 104. NKT Natural Killer (NK) Cell Therapeutics Product

Table 105. NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 106. NKT Recent Developments

Table 107. Henry Ford Health Services Company Details

Table 108. Henry Ford Health Services Business Overview

Table 109. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product

Table 110. Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)

Table 111. Henry Ford Health Services Recent Developments

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Natural Killer (NK) Cell Therapeutics Market Share by Type: 2021 VS 2028

Figure 2. Mogamulizumab Features

Figure 3. Lorvotuzumab Mertansine Features

Figure 4. Others Features

Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2021 VS 2028

Figure 6. Cancer Case Studies

Figure 7. Cardiovascular Diseases Case Studies

Figure 8. Others Case Studies

Figure 9. Natural Killer (NK) Cell Therapeutics Report Years Considered

Figure 10. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 11. Global Natural Killer (NK) Cell Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Natural Killer (NK) Cell Therapeutics Market Share by Region: 2021 VS 2028

Figure 13. Global Natural Killer (NK) Cell Therapeutics Market Share by Players in 2021

Figure 14. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2021)

Figure 15. The Top 10 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2021

Figure 16. North America Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 17. North America Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)

Figure 18. North America Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)

Figure 19. North America Natural Killer (NK) Cell Therapeutics Market Size Share by Country (2017-2028)

Figure 20. United States Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Canada Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Europe Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 23. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)

Figure 24. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)

Figure 25. Europe Natural Killer (NK) Cell Therapeutics Market Size Share by Country (2017-2028)

Figure 26. Germany Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. France Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. U.K. Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Italy Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Russia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 33. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)

Figure 34. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)

Figure 35. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size Share by Region (2017-2028)

Figure 36. China Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. Japan Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. South Korea Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. India Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Australia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 42. Latin America Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 43. Latin America Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)

Figure 44. Latin America Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)

Figure 45. Latin America Natural Killer (NK) Cell Therapeutics Market Size Share by Country (2017-2028)

Figure 46. Mexico Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Brazil Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 49. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)

Figure 50. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)

Figure 51. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size Share by Country (2017-2028)

Figure 52. Turkey Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. UAE Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. Chipscreen Biosciences Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 56. Affimed NV Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 57. Altor BioScience Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 58. Innate Pharma Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 59. Takeda Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 60. Sorrento Therapeutics Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 61. NantKwest Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 63. NKT Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 64. Henry Ford Health Services Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows multiple user to access the PDF.

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Natural Killer (NK) Cell Therapeutics Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Othe-183

Global Natural Killer (NK) Cell Therapeutics Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions